Streptomyces antibioticus synthesizes a mixture of actinomycins which differ at the "imino acid" site of the peptide chains. In the presence of exogenous pipecolic acid, several new actinomycins were synthesized and 70% of the proline in the antibiotic mixture was replaced by the analogue. Three new antibiotics (designated Pip la, Pip 113, and Pip 2) were isolated from culture filtrates, purified, and crystallized. 
in vitro, and RNA synthesis in Bacillus subtiiis and mouse L-929 cells was: actinomycin IV = Pip 113 > Pip 2 > Pip lxx. Protein synthesis in B. subtilis was less affected, and DNA synthesis was inhibited only at higher concentrations of antibiotic tested. In L cells, DNA formation was reduced less than RNA synthesis, whereas protein synthesis was not blocked under the experimental conditions employed. Kinetic studies with B. subtilis revealed that RNA synthesis was inhibited rapidly followed by an inhibition of protein synthesis. All four antibiotics markedly inhibited the replication of vaccinia virus and reovirus in tissue culture cells, but the production of poliovirus was resistant to the antibiotics. These actinomycins bind to DNA, resulting in an elevation of its Tm and a decrease in the peak extinction of the actinomycins. The mode of action, as well as the structure-activity relationships among the actinomycins, are discussed relative to a previously proposed model of binding.
The actinomycins are highly inhibitory for gram-positive bacteria, but, owing to limited cellular permeability (24, 26) , they exhibit limited or no activity against gram-negative microorganisms and fungi (30, 44) . Moreover, actinomycin IV (D) has been employed as a carcinostatic agent in the treatment of certain human neoplasms, such as Wilms' tumor and choriocarcinoma (9, 35) , although excessive toxicity of the antibiotic has restricted its potential usefulness. Studies concerning the mode of action of actinomycin IV have revealed that actinomycin is a potent inhibitor of deoxyribonucleic acid (DNA)-dependent ribonucleic acid (RNA) synthesis (16, 33) . Consequently, actinomycin has become a very useful tool for studies on the synthesis of messenger RNA and protein, as well as on the replication of viruses (32) . Streptomyces antibioticus synthesizes a number of actinomycins which differ solely at the imino acid site of the molecule (20; Fig. 1 ). The composition of an actinomycin mixture produced may vary, quantitatively and qualitatively, depending upon the conditions of cultivation (17, 40) . Previous investigations have shown that analogues of proline can influence actinomycin synthesis by competing with, and replacing, endogenously synthesized proline in certain of the actinomycin components (18, 19) . As a consequence, the formation of minor components may be greatly enhanced or the synthesis of new actinomycins may occur. In the case of pipecolic acid, the higher analogue of proline, as many as five new actinomycins are formed (19) . Three of the actinomycins (designated Pip la, Pip 113, and Pip 2) have been isolated from culture filtrates. In this report, certain biological properties of these components are described and are compared with those of actinomycin IV. 
MATERIALS AND METHODS
Radioisotopes. Uridine-2-'4C (24 mc/mmole), thymidine-2-14C ( (27) .
Test organisms and conditions of cultivation. The following microorganisms were obtained from the culture collection of the Department of Microbiology, Georgetown University Schools of Medicine and Dentistry: B. subtilis, Sarcina lutea, Staphylococcus aureus (penicillin-sensitive), S. aureus (penicillinresistant), S. albus, Escherichia coli, P. aeruginosa, Salmonella paratyphi, Aerobacter aerogenes. B. subtilis (Marburg strain) ATCC 6051 was also employed.
The bacteria were grown on Trypticase Soy Agar slants (BBL) at 37 C and then stored at 4 C. B.subtilis (Marburg) was cultivated also in Demain's medium (6) supplemented with 0.5% N-Z case (Sheffield Chemical Co., Norwich, N.Y.). Growth was measured turbidimetrically in a Klett nephelometer (filter % 54).
HeLa S3-1 and mouse L-929 cells were grown in suspension culture in Eagle's medium (7) supplemented with 5% fetal bovine or horse serum. Cell suspensions were concentrated by centrifugation and infected with poliovirus Mahoney type 1 (23) , the WR strain of vaccinia virus (36) , or the Abney strain of type 3 reovirus (41) . Virus yields were determined by plaque assay (13, 22, 36) .
Assays. The agar-streak method was used to determine the sensitivity of bacteria to the actinomycins (43) . For the measurement of biopolymer synthesis, a culture of L cells or B. subtilis (Marburg) in liquid medium was incubated with an actinomycin preparation and a 14C-labeled precursor as described in Results. The reaction was terminated by the addition of cold 5% perchloric acid (PCA). Nucleic acids were fractionated by the procedure of Schmidt and Thannhauser (39); DNA and RNA were determined by the diphenylamine test (3) and the orcinol method (28) , respectively. Protein was assayed by the method of Lowry et al. (25) . Samples were transferred to stainless-steel planchets, dried, and counted in a NuclearChicago low-background gas-flow counter.
E. coli RNA polymerase (1,800 units/mg) was purchased from Biopolymers, Inc., General Biochemicals, Chagrin Falls, Ohio, and assayed with Lcell DNA as primer, as previously described (4).
Difference spectra and melting profiles. A Cary model 11 In a study of the antimicrobial activity of the various actinomycins by the agar-streak assay method (Table 2) , actinomycin Pip 13 proved to be as active as actinomycin IV against B. subtilis, S. lutea, and S. albus. However, actinomycin Pip 13 was only one-half to one-third as active as actinomycin IV against two strains of S. aureus. By comparison, actinomycin Pip 2 was one-fifth to one-twentieth and actinomycin Pip la was onetenth to one-seventieth as active as actinomycin IV. All four antibiotics were essentially without effect against gram-negative bacteria, although a slight reduction of growth of P. aeruginosa was noted with actinomycin IV and Pip 1( at 100 ,g per ml.
Effect upon exponentially growing cultures of B. subtilis. The inhibition of an exponentially growing culture of B. subtilis (Marburg) by the various actinomycins is shown in Fig. 2 . Growth of the organism was delayed for 1 to 2 hr by 0.1 Mug of actinomycin IV per ml and was completely inhibited by 0.5 jig per ml. Similar results were obtained with actinomycin Pip 1(3. With actinomycin Pip 2 and Pip la, 0.5 and 2.0 ,ug per ml, respectively, were required for a partial inhibition of growth. For essentially complete inhibition, 2 to 5 Mig of actinomycin Pip 2 and more than 10 Mg of actinomycin Pip la per ml were required.
Microscopic examination of slides prepared from cultures exposed to the different actino- Actinomycins IV and Pip 1,6 at 100 ,zg/ml caused a slight reduction of growth of Pseudomonas aeruginosa.
mycins for 2 hr revealed a marked elongation of the inhibited cells in many instances. Actinomycin Pip la, which was the least active of the antibiotics studied, exhibited the most marked inhibition of cell division, as evidenced by the pronounced elongation and pseudobranching of cells. In the case of actinomycin Pip la (0.5 to 1.0 MAg per ml), continued cell elongation may contribute to the increase in turbidity over that of the control culture (Fig. 2) .
Inhibition of RNA, DNA, and protein synthesis in B. subtilis and L cells. The effect of actinomycins IV, Pip la, Pip 1(3, and Pip 2 on the synthesis of bacterial RNA, DNA, and protein is shown in Fig. 3 . Although all three processes were inhibited, RNA synthesis was the most sensitive of the three systems tested. Approximately 50% inhibition of RNA synthesis was achieved with actinomycins IV and Pip 1(3 at a concentration of 0.5 MAg per ml. The same level of inhibition of protein and DNA synthesis was achieved with 1 and 2 Mig of antibiotic per ml of medium, respectively. By comparison, three to four times as much actinomycin Pip 2 was needed to attain similar effects. Actinomycin Pip la was the least active compound; the concentrations required for 50% inhibition were 3.5 to 4 Mug per ml for RNA and 8 MAg per ml for protein. Only a 10% reduction in DNA synthesis was noted with 10 Mg of the antibiotic per ml of medium.
RNA synthesis in L cells was considerably more sensitive to the actinomycins than the same process in B. subtilis (Fig. 4) Fio. 2. Effect of actinomycins IV, Pip la, Pip 1p3, and Pip 2 on the growth of Bacillus subtilis. The cultures were incubated at 37 C; at the beginning ofthe exponential phase ofgrowth (arrow), the actinomycins were added at the following concentrations: 0.1, 0.5, 1.0, 2.0, 5.0, and 10 ,ug per ml ofculture. Growth was measured turbidimetrically with a Klett nephelometer. A Klett reading of5O corresponded to an optical density of0.410 at 540 mys in a Beckman DU spectrophotometer, a Klett reading of 100 was equivalent to an optical density of0.840 at 540 mp. In the latter case, the number of viable cells was 3.8 X 10) cells/ml. fourth minute of incubation, presumably the time when messenger RNA became limiting. Under the experimental conditions employed, DNA synthesis was not inhibited.
Previous investigations have shown that actinomycin IV depresses the synthesis of all species of DNA-dependent RNA, with soluble RNA synthesis the least sensitive process (8, 10, 29) . As reported above, RNA synthesis by L cells was inhibited 90 to 95% during exposure for 1 hr to 1 to 2 ,ug of actinomycin IV, Pip 1# or Pip 2 per ml. However, actinomycin Pip la depressed RNA synthesis only 40% (Fig. 4) . This finding suggested that certain species of RNA, possibly soluble RNA, were formed, whereas synthesis of other species of RNA was blocked under the conditions of antibiotic treatment. A subsequent experiment revealed that exposure of L cells to actinomycin Pip 1a (1 ,ug per ml) for a longer period of time (5 hr) inhibited RNA production by 85%, and that an additional 2-hr incubation with the antibiotic did not result in further inhibition.
The nature of the RNA species which continued to be synthesized in the presence of actinomycin Pip la was investigated. L cells were exposed to actinomycin Pip la (1 Mg per ml) for 5 hr, uridine-2-'4C (0.06 ,c/ml) was then added, and the incubation was continued for 2.5 hr. The cells were harvested and the RNA was extracted as described previously (38) . The RNA from the uninhibited and actinomycin-treated cultures was analyzed by sucrose gradient centrifugation (2). The density gradient profiles of the RNA fractions are shown in Fig. 6 . The tracings of absorbance at 260 m, and acid-precipitable radioactivity in the preparation from the uninhibited cells are similar, indicating the presence of newly formed species of 28S and 16S ribosomal RNA and 4S soluble RNA. Ribosomal precursor RNA (35 to 45S) was also present (38) . The RNA from the actinomycin-treated culture consisted of small amounts of high molecular weight material and a peak of radioactivity in the 4S region comparable to that in the uninhibited culture, suggesting that 1(3, or Pip 2. After hr, uridine-2-'4C (0.06 ,uc per ml) (A) or thymidine-2-14C (0.1 ,uc per ml) (B) was added, and the incubation was continued for hr. The cells were harvested by centrifugation (2,000 rev/mmn, 10 mn), and the pellet was suspended in ml of cold 5%
PCA. RNA and DNA were extracted and assayed as described 28 and 85%, respectively; however, the final titers increased 1,000-(Pip 2) and 200-fold (IV) as compared with the titer at 1 hr after infection (Table 3) .
Other investigators have noted a similar inhibition of poliovirus replication, and have attributed it to the strain of cells used (14) , the strain of poliovirus employed (37) , and the serum used to supplement the growth medium (5).
Effect on E. coli DNA-dependent RNA polymerase. As shown in Fig. 7 , actinomycin IV and Pip 1,B are potent inhibitors of RNA polymerase. With E. coli RNA polymerase and L-cell DNA as template, both actinomycins, at 2 Mg per ml, inhibited 3H-guanosine triphosphate incorporation into the acid-insoluble product of the enzymatic reaction by 85 to 90%. Actinomycins Pip 1a and Pip 2 were far less inhibitory; at a concentration of 10 ,ug per ml, incorporation of guanosine triphosphate label was 30% of that observed in the control.
Difference spectroscopy with actinomycin-DNA complexes. The effect of L-cell, B. subtilis, and P. aeruginosa DNA on the absorption spectrum of actinomycins IV, Pip lIa, Pip 1(3, and Pip 2 is shown in Fig. 8 The requirement for guanine residues in DNA as binding sites for actinomycin IV has been demonstrated (21) . Further, it has been pointed out that the binding of DNA to actinomycin correlates to some extent with the guanine content of the DNA used (11, 12) . The difference spectra (Fig. 8) 
DISCUSSION
The actinomycins employed previously for studies on the mechanism of action of the antibiotic have differed chiefly at the imino acid site of the molecule (33) . In particular, the variation has involved compounds of the pyrrolidine carboxylic acid series, e.g., proline, hydroxyproline, oxoproline. The actinomycins used in the present study differ in that proline is replaced by the higher analogue of proline, piperidine-2-carboxylic acid (pipecolic acid). These actinomycins were synthesized by S. antibioticus during growth in a medium containing pipecolic acid. As described in more detail elsewhere, actinomycin Pip 2 contains two residues of pipecolic acid and no proline, actinomycin Pip 1(3 contains one residue each of proline and pipecolic acid, and actinomycin Pip 1 a possesses one molecule of pipecolic acid and a second imino acid, possibly a form of hydroxyproline. equal voluime ofcold 10% PCA. RNA, DNA, and protein were extracted and assayed as described in Materials and Methods. Replicate 150-ml suspensionls ofL cells (4.2 X 10J cells/ml) were incubated in the presence (B) and absence (A) ofactinomycin Pip Ja (I ,ug/ml) and uridine-2-'4C as described in Results. RNA was extracted with phenol, dissolved in 2 ml of acetate buffer, and layered onto a 15 to 30% sucrose density gradient prepared in acetate buffer (MgCI2 omitted). After centrifugation at 25,000 rev/min for 18 hr in a Spinco S W-25.1 rotor, samples were collected through a flow cell and the optical density at 260 m,u was continuously recorded (solid line). A 2-mg amount ofcarrier RNA was added to each fraction, and the RNA was precipitated by the addition ofan equal volume ofcold 5% PCA. The precipitate was collected by centrifugation, dissolved in 0.3 N NH40H, and plated for radioactivity measurements. Actinomycin IV has been shown to inhibit DNA-directed RNA synthesis but is inhibitory to DNA synthesis only at much higher concentrations (16, 33) . The biological activity of actinomycin is believed to be due to its ability to bind to helical DNA (11) , its binding capacity paralleling the guanine content of the DNA preparation (11, 12) . A model has been proposed to explain the mechanism of antibiotic action (15) suggested that the lactone rings in actinomycin act to stabilize the peptide chains in a conformation which permits the formation of four additional H-bonds between the four peptide-NH groups and the phosphodiester oxygens of the DNA strand opposite the guanine which interacted with the chromophore. The amino acid composition of both peptide chains probably contributes to the biological activity of the actinomycin molecule; e.g., the replacement of proline by hydroxyproline can change the minimal inhibitory concentration in certain biological systems by a factor of 50 (33) . The small differences in amino acid composition of different actinomycins is thought to result in minor conformation changes of the peptide, and these changes are considered responsible for the different biological activity of the various actinomycins (34) .
The pipecolic acid-containing actinomycins (i) inhibit the growth of gram-positive bacteria but not gram-negative microorganisms (Table 2) , (ii) preferentially block RNA synthesis in both B. subtilis and mouse fibroblast cells (Fig. 3 and 4) , and (iii) inhibit E. coli DNA-dependent RNA polymerase in vitro (Fig. 7) . Further, elongated, (Fig. 9) . However, changes in the absorption spectrum of actinomycin Pip 13 in the presence of DNA resemble those obtained with actinomycin IV (Fig. 8) (20) . The binding of actinomycin to DNA is probably responsible for the biological properties of an actinomycin; however, thermal denaturation changes and difference spectra alone do not permit one to predict the biological effectiveness of an actinomycin preparation. Reich et al. (33) observed that the peak extinction of actinomycin I, Xoa, and X0a acetate were depressed as efficiently as actinomycin IV; however, actinomycin IV was shown to possess a 5-to 10-fold greater biological activity. In the present studies, the relationship for biological activity of the actinomycins (IV = Pip 113 > Pip 2 > Pip la) does not appear to hold completely for either the elevation of Tm or the effect of DNA upon the antibiotic absorption spectrum. More sensitive methods of measuring binding (e.g., equilibrium dialysis) may prove useful in relating binding capacity to biological activity. The actinomycin peptides may or may not be symmetrical (Fig. 1) ; consequently, the composition of each peptide chain may be of considerable importance with respect to biological activity and binding to DNA. In the case of actinomycin Pip 11, it is not known whether the pipecolic acid is located in the A or B chain. Determination of its position might provide a better understanding for the biological behavior noted with actinomycins IV and Pip 113.
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